In a unanimous decision issued on May 28, 2026, the U.S. Supreme Court ruled in Flowers Foods, Inc. v. Brock on the scope of the transportation worker exemption under the Federal Arbitration
Saturday’s racing card may be slightly quieter than recent weeks, but Newbury’s Group Three Hackwood Stakes at 3.02pm still offers plenty of interest for punters. The market leaders Marvelman and Kind Of
More
Employers across the United States are quietly abandoning pre-employment marijuana testing even as positive test results reach their highest levels in years. New workforce data from Quest Diagnostics, drawn from roughly eight
More
The FTSE 100 (^FTSE) recovered from a weak opening to close in positive territory on Tuesday, buoyed by unexpectedly soft American inflation data. London’s blue-chip index ended the session up 31.10 points,
More
Consumer prices recorded their steepest monthly decline in more than six years during June, offering Americans temporary relief from a persistent inflation surge. The consumer price index fell a seasonally adjusted 0.4%
More
IBM shares are on course for their worst trading session in decades after the tech giant warned customers are redirecting spending toward AI infrastructure and away from software. The selloff wiped more
More
The pharmaceutical distribution sector is undergoing a significant transformation, driven by the need to balance highly targeted delivery models with large-scale operational demands. Modern drug supply chains are increasingly complex, requiring distributors
More
The Federal Aviation Administration has proposed ending its long-standing prohibition on overland civil supersonic flight, replacing the blanket ban with a performance-based noise standard. The FAA originally established the prohibition in 1973
More
BP has revealed an additional $1bn (£750m) write-down from its struggling energy transition division, dealing another blow to the embattled oil giant. The FTSE 100-listed company said it expected to write down
More
Quantum computing is emerging as one of the most closely watched sectors in technology investment circles, drawing significant attention from analysts and institutional investors alike. The United States government has been ramping
More
GSK is preparing to seek FDA accelerated approval for its cancer drug Jemperli after a phase 2 trial delivered a significant clinical win in a high-profile cancer indication. Interim results from the
More